Group 1 - BNP Paribas has published the third amendment to its Universal registration document and annual financial report for 2023, dated March 22, 2024 [1] - The amendment was filed with the Autorité des Marchés Financiers (AMF) on October 31, 2024, and is listed under number D.24-0158-A03 [1] - The document is accessible on BNP Paribas' website and the AMF website [2]

PHOENIX, Oct. 30, 2024 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI) (the "Company"), a leading workforce solutions provider, will hold a conference call on Wednesday, November 20, 2024, at 4:30 p.m. Eastern time to discuss its financial and operational results for the fiscal fourth quarter and full year ended September 30, 2024.The Company's CEO, Jerome Grant, and Interim CFO, Christine Kline, will host the conference call, followed by a question-and-answer session.Conference Call Date: W ...

Q3 2024 Net Sales are a record $87.3 million; Aerospace sales top $200 million YTD Q3 2024 Net Income increased to record $11.1 million, or $1.11 per diluted share Gross Margin remained strong at 25.2% of sales BRIDGEVILLE, Pa., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) today reported record net sales of $87.3 million for the third quarter of 2024, an increase of 5% from the second quarter of 2024, and up 22% from the third quarter of 2023. Year-to-date net ...

Bloomingdale's announces a holiday partnership with Universal Pictures' new cinematic event, Wicked; with immersive activations, exclusive products including an AQUA collaboration, and their annual 59th Street window unveiling. NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Bloomingdale's announces its Wicked Good Holiday campaign in partnership with Universal Pictures' spectacular new cinematic event, Wicked, the untold story of the witches of Oz. This collaboration will bring the magic of the holidays to life wi ...

Universal Health Services, Inc. (UHS) reported third-quarter 2024 adjusted earnings per share (EPS) of $3.71, which missed the Zacks Consensus Estimate by 1.1%. Nevertheless, the bottom line climbed 45.5% year over year.Net revenues advanced 11.2% year over year to nearly $4 billion. The top line beat the consensus mark by 1.4%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Universal Health’s quarterly performance suffered from an elevated operating expense level. Nevertheless, the ...

NEW YORK, Oct. 25, 2024 /PRNewswire/ -- WeRide, the leading global commercial-stage company, was officially listed on the Nasdaq Global Select Market under the ticker symbol "WRD." Upon listing, WeRide became the world's first publicly listed universal autonomous driving technology company and the first publicly listed Robotaxi company. The initial public offering price was set at $15.5 per American depositary share (ADS). If the underwriters fully exercise the granted option, the Company will issue a total ...

Third Quarter 2024 Operating Revenues: $426.8 million, 1.3% increase Third Quarter 2024 Operating Income: $42.6 million, 16.0% increase Third Quarter 2024 Earnings Per Share: $1.01 per share, 14.7% increase Declares Quarterly Dividend: $0.105 per shareWARREN, Mich., Oct. 24, 2024 /PRNewswire/ -- Universal Logistics Holdings, Inc. (NASDAQ: ULH) today reported consolidated third quarter 2024 net income of $26.5 million, or $1.01 per basic and diluted share, on total operating revenues of $426.8 million. This ...

Delivery of Prime Editors with a proprietary, universal liver-targeted LNP was well tolerated, with no safety concerns or detectable off-target edits observed across multiple preclinical studies On track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND and/or CTA filing expected in 1H 2026 CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative ...

Core Viewpoint - Universal Health Services, Inc. (UHS) is expected to report strong earnings growth for Q3 2024, driven by increased admissions and demand for behavioral healthcare services, despite facing rising expenses [1][4][6]. Financial Performance - The Zacks Consensus Estimate for earnings per share is $3.75, reflecting a 47.1% increase from the prior-year quarter [1]. - The estimated revenue for Q3 is $3.9 billion, indicating a 9.7% growth year-over-year [2]. - UHS has a history of beating consensus estimates, with an average surprise of 14.58% over the last four quarters [2]. Segment Performance - The Acute Care Hospital Services segment is projected to generate $2.2 billion in revenue, representing an 8.1% year-over-year growth, supported by increased adjusted admissions [5]. - The Behavioral Health Care Services segment is expected to achieve $1.7 billion in revenue, indicating an 11.1% increase from the previous year, driven by sustained demand for mental health services [5]. Cost Pressures - Rising overall expenses, particularly in salaries, wages, and supplies, are anticipated to pressure margins, with salaries expected to rise by 6.1% and supplies by 7.5% [6]. Stock Performance and Valuation - UHS shares have increased by 89.4% over the past year, outperforming the industry and broader market indices [7]. - The current trading valuation of UHS is 13.81X forward 12-month earnings, below the industry average of 16.29X, indicating a potentially attractive investment opportunity [9]. Future Prospects - The resumption of deferred elective procedures is expected to enhance patient volumes and occupancy levels, contributing to future growth [11]. - UHS has a projected earnings growth rate of 19% over the next five years, surpassing the industry average of 14.8% [11]. - The company maintains a strong commitment to shareholder returns through dividends and share repurchases, supported by robust cash flows [11]. Conclusion - Despite challenges from elevated operating expenses, the strong performance of UHS's segments and its lower valuation compared to the industry make it an appealing investment option [12].

NEW YORK, Oct. 18, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Universal Stainless & Alloy Products, Inc. (NASDAQ: USAP) and its board of directors concerning the proposed acquisition of the company by Aperam. Stockholders will receive $45.00 for each share of Universal Stainless stock that they hold. The transaction is expected to close in the first quarter of 2025. If you are a stockholder of Universal Stainless & Alloy Products, Inc. and are interested in ...